Last updated: May 29, 2026

Application No. 17/761,830

NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PREVENTING, AMELIORATING, OR TREATING PROTEINOPATHIES

Final Rejection

Filed

Mar 18, 2022

Priority

Sep 20, 2019 — provisional 62/903,489 +1 more

Examiner

YOO, SUN JAE

Art Unit

1621

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Seoul National University R&Db Foundation

OA Round

4 (Final)

Interview Optional

— +0.0% interview lift. Interview lift (+0.0%) is below the 15.0% threshold. A written response is recommended.

Based on 1227 resolved cases, 2023–2026

Examiner Intelligence

YOO, SUN JAE View full profile →

Grants 71% — above average

Career Allowance Rate

871 granted / 1227 resolved

+11.0% vs TC avg

Minimal +0% lift

Without

With

+0.0%

Interview Lift

resolved cases with interview

Typical timeline

2y 8m

Avg Prosecution

97 currently pending

Career history

1279

Total Applications

across all art units

Statute-Specific Performance

§101

0.7%

-39.3% vs TC avg

§103

20.1%

-19.9% vs TC avg

§102

27.4%

-12.6% vs TC avg

§112

24.1%

-15.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1227 resolved cases

Prosecution Timeline

Show 2 earlier events

Mar 04, 2025

Response Filed

May 28, 2025

Final Rejection mailed

Aug 27, 2025

Response after Non-Final Action

Sep 26, 2025

Request for Continued Examination

Oct 07, 2025

Response after Non-Final Action

Jan 27, 2026

Non-Final Rejection mailed

Apr 27, 2026

Response Filed

May 27, 2026

Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/907,174

Patent 12637455

NAPHTHYRIDINE AND PYRIDO[3,4-c]PYRIDAZINE DERIVATIVES AS GABAA ALPHA 5 RECEPTOR MODULATORS

3y 8m to grant Granted May 26, 2026

18/613,641

Patent 12636280

Therapeutic Tyrosine Kinase Inhibitors for Relapsing Multiple Sclerosis (RMS)

2y 2m to grant Granted May 26, 2026

18/289,437

Patent 12635400

ORGANOMETALLIC COMPOUND AND APPLICATION THEREOF

2y 6m to grant Granted May 19, 2026

17/771,344

Patent 12623997

Non-Coordinating Anion Activators Containing a Cation with Long Chain Alkoxy Functionalization

4y 0m to grant Granted May 12, 2026

18/006,068

Patent 12612377

PROCESS FOR PREPARING AMINOFURANES

3y 3m to grant Granted Apr 28, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6

Expected OA Rounds

71%

Grant Probability

71%

With Interview (+0.0%)

2y 8m (~0m remaining)

Median Time to Grant

High

PTA Risk

Based on 1227 resolved cases by this examiner. Grant probability derived from career allowance rate.